title: The placebo response: relationship to outcomes in trials of postherpetic neuralgia.
abstract: Placebo responses in controlled studies of neuropathic pain, including postherpetic neuralgia, have increased in recent years and may obscure benefits of potential treatments. Investigations of the basis of the placebo effect have revealed some of the anatomical and physiological substrates for these responses. Placebo responses are accompanied by changes in activity in brain regions involved in analgesia, pain processing, reward and emotion, and they involve neurotransmitters with well established roles in pain modulation, including opioids and cholecystokinin. These findings may eventually provide useful suggestions for limiting placebo responses in clinical trials as identification of the cues that contribute to placebo responses could conceivably permit their avoidance in the design of clinical studies. Analyses of the characteristics of clinical trials in neuropathic pain have revealed some factors that might also help explain the increase in placebo responses. These factors include the longer duration of contemporary trials and recruitment practices of high-enrolling study centres. In trials of patients with postherpetic neuralgia, inclusion of patients with a short duration of post-zoster pain can result in a high rate of spontaneous remission that can contribute to an apparent 'placebo response'. Future placebo-controlled trials of treatments for postherpetic neuralgia may need to consider modifications of the design and conduct of these studies to maximize the chance of obtaining valid study results.
authors.affiliation: Swedish Pain and Headache Center, Seattle, Washington 98104, USA. gordon.irving@swedish.org
authors.forename: Gordon
authors.initials: G
authors.lastname: Irving
mesh_terms: D018849:Controlled Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D051474:Neuralgia, Postherpetic / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D010147:Pain Measurement; D018579:Patient Selection; D015990:Placebo Effect; D012075:Remission, Spontaneous; D012107:Research Design; D013997:Time Factors; D016896:Treatment Outcome
references.citation: Annu Rev Pharmacol Toxicol. 2008;48:33-60
references.pmid: 17666008
references.citation: Pain. 1991 Jul;46(1):43-51
references.pmid: 1896207
references.citation: QJM. 2005 Jan;98(1):29-34
references.pmid: 15625351
references.citation: Qual Inq. 2007 Sep;13(6):875-894
references.pmid: 21359125
references.citation: Anesthesiology. 2002 May;96(5):1053-61
references.pmid: 11981142
references.citation: Fundam Clin Pharmacol. 1995;9(5):409-33
references.pmid: 8617406
references.citation: Pain. 2009 Dec;146(3):261-269
references.pmid: 19781854
references.citation: N Engl J Med. 2005 Jun 2;352(22):2271-84
references.pmid: 15930418
references.citation: Clin J Pain. 2002 Sep-Oct;18(5):297-301
references.pmid: 12218500
references.citation: Neuron. 2007 Jul 19;55(2):325-36
references.pmid: 17640532
references.citation: J Opioid Manag. 2006 May-Jun;2(3):167-73
references.pmid: 17319450
references.citation: Neurology. 2005 Dec 29;65(12 Suppl 4):S7-19
references.pmid: 16385107
references.citation: Pain. 2001 Nov;94(2):215-224
references.pmid: 11690735
references.citation: J Pain. 2009 Jun;10(6):654-60
references.pmid: 19409858
references.citation: Pain. 2008 Jun;136(3):419-431
references.pmid: 18400400
references.citation: Annu Rev Psychol. 2008;59:565-90
references.pmid: 17550344
references.citation: Pain. 2002 Oct;99(3):443-452
references.pmid: 12406519
references.citation: Pain. 2005 Jun;115(3):338-347
references.pmid: 15911161
references.citation: Clin J Pain. 2000 Sep;16(3):188-92
references.pmid: 11014390
references.citation: J Pain Symptom Manage. 1999 Jun;17(6):429-33
references.pmid: 10388248
references.citation: Pain. 2010 Mar;148(3):368-374
references.pmid: 19875233
references.citation: Pain. 2007 Apr;128(3):264-271
references.pmid: 17257756
references.citation: J Pain. 2008 Nov;9(11):1006-17
references.pmid: 18640074
references.citation: Pain. 2009 Sep;145(1-2):36-44
references.pmid: 19559529
references.citation: Clin Ther. 1993 May-Jun;15(3):510-26
references.pmid: 8364943
references.citation: Neurology. 2008 Jan 22;70(4):263-72
references.pmid: 17914067
references.citation: Pain. 2008 Apr;135(3):217-220
references.pmid: 18258369
references.citation: Neurology. 2003 Apr 22;60(8):1274-83
references.pmid: 12707429
references.citation: J Infect Dis. 1998 Nov;178 Suppl 1:S71-5
references.pmid: 9852979
references.citation: Clin Pharmacol Ther. 1990 Mar;47(3):305-12
references.pmid: 2178851
references.citation: JAMA. 1998 Dec 2;280(21):1837-42
references.pmid: 9846778
references.citation: Neurology. 1988 Sep;38(9):1427-32
references.pmid: 3412591
references.citation: Science. 2004 Feb 20;303(5661):1162-7
references.pmid: 14976306
references.citation: Neuron. 2008 Jul 31;59(2):195-206
references.pmid: 18667148
references.citation: Curr Med Res Opin. 2006 Feb;22(2):375-84
references.pmid: 16466610
references.citation: J Pain Symptom Manage. 1999 Mar;17(3):175-80
references.pmid: 10098360
references.citation: Br J Clin Pharmacol. 2008 Aug;66(2):266-75
references.pmid: 18489611
references.citation: Spine (Phila Pa 1976). 1996 Feb 1;21(3):345-55
references.pmid: 8742212
references.citation: Science. 2002 Mar 1;295(5560):1737-40
references.pmid: 11834781
references.citation: Br J Anaesth. 2002 Nov;89(5):711-4
references.pmid: 12393768
references.citation: Pain. 2009 Sep;145(1-2):24-30
references.pmid: 19523766
references.citation: Lancet Neurol. 2008 Dec;7(12):1106-12
references.pmid: 18977178
references.citation: Pain. 1996 Apr;65(1):45-51
references.pmid: 8826489
references.citation: Pain. 2003 Jul;104(1-2):323-31
references.pmid: 12855342
references.citation: Clin J Pain. 2009 Mar-Apr;25(3):185-92
references.pmid: 19333167
references.citation: Pain. 2009 Nov;146(1-2):194-8
references.pmid: 19692178
references.citation: J Neurosci. 2006 Nov 15;26(46):12014-22
references.pmid: 17108175
references.citation: Pain. 2008 Jun;136(3):232-234
references.pmid: 18384959
references.citation: Pain. 2000 Jan;84(1):65-75
references.pmid: 10601674
references.citation: Pain. 2008 Sep 15;138(3):479-483
references.pmid: 18706762
references.citation: Clin Drug Investig. 2010;30(11):765-76
references.pmid: 20818838
references.citation: Neuron. 2005 Jun 16;46(6):957-69
references.pmid: 15953423
references.citation: Clin J Pain. 2009 Jul-Aug;25(6):469-76
references.pmid: 19542793
references.citation: N Engl J Med. 1996 Jul 4;335(1):32-42
references.pmid: 8637540
references.citation: Aging Clin Exp Res. 2009 Jun;21(3):236-43
references.pmid: 19571648
references.citation: Pain. 2007 Jan;127(1-2):63-72
references.pmid: 16963184
references.citation: Neurology. 1991 Jul;41(7):1024-8
references.pmid: 1712433
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2005 Dec;29(8):1225-38
references.pmid: 16242828
references.citation: Clin J Pain. 2002 Nov-Dec;18(6):343-9
references.pmid: 12441827
references.citation: Neurology. 2002 Oct 8;59(7):1015-21
references.pmid: 12370455
references.citation: Clin J Pain. 2009 Jun;25(5):365-75
references.pmid: 19454869